Home  »  Business   »  Baxter International Inc. (BAX) and the Battle of ...

Baxter International Inc. (BAX) and the Battle of Fundamentals vs. Technicals

Baxter International Inc. (NYSE:BAX) went down by -1.96% from its latest closing price compared to the recent 1-year high of $89.70. The company’s stock price has collected -6.16% of loss in the last five trading sessions. The Wall Street Journal reported on 09/02/21 that Bitcoin, Virgin Galactic, Chewy, Quanta: What to Watch When the Stock Market Opens Today

Is It Worth Investing in Baxter International Inc. (NYSE :BAX) Right Now?

Baxter International Inc. (NYSE:BAX) scored a price-to-earnings ratio above its average ratio, recording 27.79 x from its present earnings ratio. Plus, the 36-month beta value for BAX is at 0.60.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


The average price from analysts is $68.67, which is $15.11 above the current price. BAX currently public float of 502.58M and currently shorts hold a 1.01% ratio of that float. Today, the average trading volume of BAX was 3.04M shares.

BAX’s Market Performance

BAX stocks went down by -6.16% for the week, with a monthly drop of -7.04% and a quarterly performance of -14.33%, while its annual performance rate touched -32.31%. The volatility ratio for the week stands at 2.79% while the volatility levels for the past 30 days are set at 2.71% for Baxter International Inc. The simple moving average for the period of the last 20 days is -4.29% for BAX stocks with a simple moving average of -24.87% for the last 200 days.

Analysts’ Opinion of BAX

Many brokerage firms have already submitted their reports for BAX stocks, with Wells Fargo repeating the rating for BAX by listing it as a “Equal Weight.” The predicted price for BAX in the upcoming period, according to Wells Fargo is $71 based on the research report published on June 24th of the current year 2022.

Goldman, on the other hand, stated in their research note that they expect to see BAX reach a price target of $77, previously predicting the price at $88. The rating they have provided for BAX stocks is “Sell” according to the report published on April 04th, 2022.

BofA Securities gave a rating of “Buy” to BAX, setting the target price at $100 in the report published on March 02nd of the current year.

BAX Trading at -8.16% from the 50-Day Moving Average

After a stumble in the market that brought BAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.16% of loss for the given period.

Volatility was left at 2.71%, however, over the last 30 days, the volatility rate increased by 2.79%, as shares sank -5.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.24% lower at present.

During the last 5 trading sessions, BAX fell by -6.16%, which changed the moving average for the period of 200-days by -28.93% in comparison to the 20-day moving average, which settled at $57.80. In addition, Baxter International Inc. saw -35.38% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BAX starting from HELLMAN PETER S, who sale 4,020 shares at the price of $76.02 back on Apr 05. After this action, HELLMAN PETER S now owns 27,629 shares of Baxter International Inc., valued at $305,593 using the latest closing price.

STROUCKEN ALBERT P L, the Director of Baxter International Inc., sale 4,020 shares at $76.02 during a trade that took place back on Apr 05, which means that STROUCKEN ALBERT P L is holding 34,127 shares at $305,612 based on the most recent closing price.

Stock Fundamentals for BAX

Current profitability levels for the company are sitting at:

  • +16.29 for the present operating margin
  • +40.83 for the gross margin

The net margin for Baxter International Inc. stands at +10.04. Equity return is now at value 11.30, with 3.40 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 2.09.

Is Amicus Therapeutics Inc. (FOLD) a Keeper?

Amicus Therapeutics Inc. (NASDAQ:FOLD) went up by 0.18% from its latest closing price compared to the recent 1-year high of $12.96. The company’s stock price